img

Global Immune Globulin Subcutaneous Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immune Globulin Subcutaneous Market Insights, Forecast to 2034

Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
Global Immune Globulin Subcutaneous market is expected to reach to US$ 1987 million in 2024, with a positive growth of %, compared with US$ 1864 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Immune Globulin Subcutaneous industry is evaluated to reach US$ 2786.8 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
Globally, Immune Globulin Subcutaneous key manufacturers include Takeda and CSL etc. Takeda, CSL, are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Immune Globulin Subcutaneous were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Immune Globulin Subcutaneous market and estimated to attract more attentions from industry insiders and investors.
Immune Globulin Subcutaneous can be divided into 2g, 4g, 10g and Other, etc. 2g is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Immune Globulin Subcutaneous is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Immune Globulin Subcutaneous industry development. In 2022, global % sales of Immune Globulin Subcutaneous went into Immunodeficiency filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Immune Globulin Subcutaneous market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Immune Globulin Subcutaneous market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
CSL
Segment by Type
2g
4g
10g
Other

Segment by Application


Immunodeficiency
Autoimmune Disease
Acute Infection

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Immune Globulin Subcutaneous plant distribution, commercial date of Immune Globulin Subcutaneous, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Immune Globulin Subcutaneous introduction, etc. Immune Globulin Subcutaneous Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Immune Globulin Subcutaneous
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Immune Globulin Subcutaneous Product Introduction
1.2 Market by Type
1.2.1 Global Immune Globulin Subcutaneous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 2g
1.2.3 4g
1.2.4 10g
1.2.5 Other
1.3 Market by Application
1.3.1 Global Immune Globulin Subcutaneous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immune Globulin Subcutaneous Sales Estimates and Forecasts 2018-2029
2.2 Global Immune Globulin Subcutaneous Revenue by Region
2.2.1 Global Immune Globulin Subcutaneous Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Immune Globulin Subcutaneous Revenue by Region (2018-2024)
2.2.3 Global Immune Globulin Subcutaneous Revenue by Region (2024-2029)
2.2.4 Global Immune Globulin Subcutaneous Revenue Market Share by Region (2018-2029)
2.3 Global Immune Globulin Subcutaneous Sales Estimates and Forecasts 2018-2029
2.4 Global Immune Globulin Subcutaneous Sales by Region
2.4.1 Global Immune Globulin Subcutaneous Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Immune Globulin Subcutaneous Sales by Region (2018-2024)
2.4.3 Global Immune Globulin Subcutaneous Sales by Region (2024-2029)
2.4.4 Global Immune Globulin Subcutaneous Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Immune Globulin Subcutaneous Sales by Manufacturers
3.1.1 Global Immune Globulin Subcutaneous Sales by Manufacturers (2018-2024)
3.1.2 Global Immune Globulin Subcutaneous Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immune Globulin Subcutaneous in 2022
3.2 Global Immune Globulin Subcutaneous Revenue by Manufacturers
3.2.1 Global Immune Globulin Subcutaneous Revenue by Manufacturers (2018-2024)
3.2.2 Global Immune Globulin Subcutaneous Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Immune Globulin Subcutaneous Revenue in 2022
3.3 Global Key Players of Immune Globulin Subcutaneous, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Immune Globulin Subcutaneous Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immune Globulin Subcutaneous, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immune Globulin Subcutaneous, Product Offered and Application
3.8 Global Key Manufacturers of Immune Globulin Subcutaneous, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immune Globulin Subcutaneous Sales by Type
4.1.1 Global Immune Globulin Subcutaneous Historical Sales by Type (2018-2024)
4.1.2 Global Immune Globulin Subcutaneous Forecasted Sales by Type (2024-2029)
4.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
4.2 Global Immune Globulin Subcutaneous Revenue by Type
4.2.1 Global Immune Globulin Subcutaneous Historical Revenue by Type (2018-2024)
4.2.2 Global Immune Globulin Subcutaneous Forecasted Revenue by Type (2024-2029)
4.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
4.3 Global Immune Globulin Subcutaneous Price by Type
4.3.1 Global Immune Globulin Subcutaneous Price by Type (2018-2024)
4.3.2 Global Immune Globulin Subcutaneous Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Immune Globulin Subcutaneous Sales by Application
5.1.1 Global Immune Globulin Subcutaneous Historical Sales by Application (2018-2024)
5.1.2 Global Immune Globulin Subcutaneous Forecasted Sales by Application (2024-2029)
5.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
5.2 Global Immune Globulin Subcutaneous Revenue by Application
5.2.1 Global Immune Globulin Subcutaneous Historical Revenue by Application (2018-2024)
5.2.2 Global Immune Globulin Subcutaneous Forecasted Revenue by Application (2024-2029)
5.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
5.3 Global Immune Globulin Subcutaneous Price by Application
5.3.1 Global Immune Globulin Subcutaneous Price by Application (2018-2024)
5.3.2 Global Immune Globulin Subcutaneous Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Immune Globulin Subcutaneous Market Size by Type
6.1.1 US & Canada Immune Globulin Subcutaneous Sales by Type (2018-2029)
6.1.2 US & Canada Immune Globulin Subcutaneous Revenue by Type (2018-2029)
6.2 US & Canada Immune Globulin Subcutaneous Market Size by Application
6.2.1 US & Canada Immune Globulin Subcutaneous Sales by Application (2018-2029)
6.2.2 US & Canada Immune Globulin Subcutaneous Revenue by Application (2018-2029)
6.3 US & Canada Immune Globulin Subcutaneous Market Size by Country
6.3.1 US & Canada Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Immune Globulin Subcutaneous Sales by Country (2018-2029)
6.3.3 US & Canada Immune Globulin Subcutaneous Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Immune Globulin Subcutaneous Market Size by Type
7.1.1 Europe Immune Globulin Subcutaneous Sales by Type (2018-2029)
7.1.2 Europe Immune Globulin Subcutaneous Revenue by Type (2018-2029)
7.2 Europe Immune Globulin Subcutaneous Market Size by Application
7.2.1 Europe Immune Globulin Subcutaneous Sales by Application (2018-2029)
7.2.2 Europe Immune Globulin Subcutaneous Revenue by Application (2018-2029)
7.3 Europe Immune Globulin Subcutaneous Market Size by Country
7.3.1 Europe Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Immune Globulin Subcutaneous Sales by Country (2018-2029)
7.3.3 Europe Immune Globulin Subcutaneous Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Immune Globulin Subcutaneous Market Size
8.1.1 China Immune Globulin Subcutaneous Sales (2018-2029)
8.1.2 China Immune Globulin Subcutaneous Revenue (2018-2029)
8.2 China Immune Globulin Subcutaneous Market Size by Application
8.2.1 China Immune Globulin Subcutaneous Sales by Application (2018-2029)
8.2.2 China Immune Globulin Subcutaneous Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immune Globulin Subcutaneous Market Size by Type
9.1.1 Asia Immune Globulin Subcutaneous Sales by Type (2018-2029)
9.1.2 Asia Immune Globulin Subcutaneous Revenue by Type (2018-2029)
9.2 Asia Immune Globulin Subcutaneous Market Size by Application
9.2.1 Asia Immune Globulin Subcutaneous Sales by Application (2018-2029)
9.2.2 Asia Immune Globulin Subcutaneous Revenue by Application (2018-2029)
9.3 Asia Immune Globulin Subcutaneous Sales by Region
9.3.1 Asia Immune Globulin Subcutaneous Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Immune Globulin Subcutaneous Revenue by Region (2018-2029)
9.3.3 Asia Immune Globulin Subcutaneous Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immune Globulin Subcutaneous Market Size by Type
10.1.1 Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Immune Globulin Subcutaneous Market Size by Application
10.2.1 Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Country
10.3.1 Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Immune Globulin Subcutaneous Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Immune Globulin Subcutaneous Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Immune Globulin Subcutaneous Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Immune Globulin Subcutaneous Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immune Globulin Subcutaneous Industry Chain Analysis
12.2 Immune Globulin Subcutaneous Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immune Globulin Subcutaneous Production Mode & Process
12.4 Immune Globulin Subcutaneous Sales and Marketing
12.4.1 Immune Globulin Subcutaneous Sales Channels
12.4.2 Immune Globulin Subcutaneous Distributors
12.5 Immune Globulin Subcutaneous Customers
13 Market Dynamics
13.1 Immune Globulin Subcutaneous Industry Trends
13.2 Immune Globulin Subcutaneous Market Drivers
13.3 Immune Globulin Subcutaneous Market Challenges
13.4 Immune Globulin Subcutaneous Market Restraints
14 Key Findings in The Global Immune Globulin Subcutaneous Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Immune Globulin Subcutaneous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 2g
Table 3. Major Manufacturers of 4g
Table 4. Major Manufacturers of 10g
Table 5. Major Manufacturers of Other
Table 6. Global Immune Globulin Subcutaneous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Immune Globulin Subcutaneous Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Immune Globulin Subcutaneous Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Immune Globulin Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2018-2024)
Table 11. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2024-2029)
Table 12. Global Immune Globulin Subcutaneous Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Immune Globulin Subcutaneous Sales by Region (2018-2024) & (K Units)
Table 14. Global Immune Globulin Subcutaneous Sales by Region (2024-2029) & (K Units)
Table 15. Global Immune Globulin Subcutaneous Sales Market Share by Region (2018-2024)
Table 16. Global Immune Globulin Subcutaneous Sales Market Share by Region (2024-2029)
Table 17. Global Immune Globulin Subcutaneous Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Immune Globulin Subcutaneous Sales Share by Manufacturers (2018-2024)
Table 19. Global Immune Globulin Subcutaneous Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Immune Globulin Subcutaneous Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Immune Globulin Subcutaneous, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Immune Globulin Subcutaneous Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Immune Globulin Subcutaneous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Immune Globulin Subcutaneous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Subcutaneous as of 2022)
Table 25. Global Key Manufacturers of Immune Globulin Subcutaneous, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Immune Globulin Subcutaneous, Product Offered and Application
Table 27. Global Key Manufacturers of Immune Globulin Subcutaneous, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 30. Global Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 31. Global Immune Globulin Subcutaneous Sales Share by Type (2018-2024)
Table 32. Global Immune Globulin Subcutaneous Sales Share by Type (2024-2029)
Table 33. Global Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Immune Globulin Subcutaneous Revenue Share by Type (2018-2024)
Table 36. Global Immune Globulin Subcutaneous Revenue Share by Type (2024-2029)
Table 37. Immune Globulin Subcutaneous Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Immune Globulin Subcutaneous Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 40. Global Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 41. Global Immune Globulin Subcutaneous Sales Share by Application (2018-2024)
Table 42. Global Immune Globulin Subcutaneous Sales Share by Application (2024-2029)
Table 43. Global Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Immune Globulin Subcutaneous Revenue Share by Application (2018-2024)
Table 46. Global Immune Globulin Subcutaneous Revenue Share by Application (2024-2029)
Table 47. Immune Globulin Subcutaneous Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Immune Globulin Subcutaneous Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Immune Globulin Subcutaneous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 62. Europe Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 63. Europe Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 64. Europe Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 67. Europe Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 68. Europe Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Immune Globulin Subcutaneous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 74. Europe Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 75. China Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 76. China Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 77. China Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 80. China Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 81. China Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 84. Asia Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 85. Asia Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 88. Asia Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 89. Asia Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Immune Globulin Subcutaneous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Immune Globulin Subcutaneous Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Immune Globulin Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Immune Globulin Subcutaneous Sales by Region (2018-2024) & (K Units)
Table 95. Asia Immune Globulin Subcutaneous Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Takeda Immune Globulin Subcutaneous Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. CSL Company Information
Table 115. CSL Description and Major Businesses
Table 116. CSL Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. CSL Immune Globulin Subcutaneous Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CSL Recent Developments
Table 119. Key Raw Materials Lists
Table 120. Raw Materials Key Suppliers Lists
Table 121. Immune Globulin Subcutaneous Distributors List
Table 122. Immune Globulin Subcutaneous Customers List
Table 123. Immune Globulin Subcutaneous Market Trends
Table 124. Immune Globulin Subcutaneous Market Drivers
Table 125. Immune Globulin Subcutaneous Market Challenges
Table 126. Immune Globulin Subcutaneous Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Globulin Subcutaneous Product Picture
Figure 2. Global Immune Globulin Subcutaneous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Immune Globulin Subcutaneous Market Share by Type in 2022 & 2029
Figure 4. 2g Product Picture
Figure 5. 4g Product Picture
Figure 6. 10g Product Picture
Figure 7. Other Product Picture
Figure 8. Global Immune Globulin Subcutaneous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Immune Globulin Subcutaneous Market Share by Application in 2022 & 2029
Figure 10. Immunodeficiency
Figure 11. Autoimmune Disease
Figure 12. Acute Infection
Figure 13. Immune Globulin Subcutaneous Report Years Considered
Figure 14. Global Immune Globulin Subcutaneous Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Immune Globulin Subcutaneous Revenue 2018-2029 (US$ Million)
Figure 16. Global Immune Globulin Subcutaneous Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2018-2029)
Figure 18. Global Immune Globulin Subcutaneous Sales 2018-2029 ((K Units)
Figure 19. Global Immune Globulin Subcutaneous Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Immune Globulin Subcutaneous Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Immune Globulin Subcutaneous Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Immune Globulin Subcutaneous Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Immune Globulin Subcutaneous Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Immune Globulin Subcutaneous Sales YoY (2018-2029) & (K Units)
Figure 25. China Immune Globulin Subcutaneous Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Immune Globulin Subcutaneous Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Immune Globulin Subcutaneous Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Immune Globulin Subcutaneous Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Immune Globulin Subcutaneous in the World: Market Share by Immune Globulin Subcutaneous Revenue in 2022
Figure 32. Global Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 34. Global Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 35. Global Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 36. Global Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Immune Globulin Subcutaneous Revenue Share by Country (2018-2029)
Figure 42. US & Canada Immune Globulin Subcutaneous Sales Share by Country (2018-2029)
Figure 43. U.S. Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 46. Europe Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 47. Europe Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 48. Europe Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 49. Europe Immune Globulin Subcutaneous Revenue Share by Country (2018-2029)
Figure 50. Europe Immune Globulin Subcutaneous Sales Share by Country (2018-2029)
Figure 51. Germany Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 52. France Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 53. UK Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 56. China Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 57. China Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 58. China Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 59. China Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 60. Asia Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 61. Asia Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 62. Asia Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 63. Asia Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 64. Asia Immune Globulin Subcutaneous Revenue Share by Region (2018-2029)
Figure 65. Asia Immune Globulin Subcutaneous Sales Share by Region (2018-2029)
Figure 66. Japan Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 70. India Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Immune Globulin Subcutaneous Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Immune Globulin Subcutaneous Sales Share by Country (2018-2029)
Figure 77. Brazil Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Immune Globulin Subcutaneous Revenue (2018-2029) & (US$ Million)
Figure 82. Immune Globulin Subcutaneous Value Chain
Figure 83. Immune Globulin Subcutaneous Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed